←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS80%
R&D + SG&A13%
Op Margin7%
FINANCIAL HEALTH
REVENUE
$450.5B
Growth
0%
Gross M.
20%
P/E
25.3
EV/EBITDA
14.9
Net M.
3%
FCF M.
5%
D/E
0.83
Op M.
7%
PLUG INTO YOUR DCF
Historical growth
11.7%
Analyst 5y growth
—
Forward P/E
17.3
PEG ratio
1.20
Trailing EPS
$15.40
Forward EPS
$22.40
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
MEDTrading above a mechanical base-case DCF estimate of $378.75 (default assumptions) — priced for continued strong execution.
LOWDebt/equity of 0.83 — conservative balance sheet.
LOWRevenue growing 0% YoY — steady, unspectacular growth.
🐂 BULL
UNH shows revenue grew +0.4% YoY, 7% operating margin, 14% ROE — a business converting growth into real profit.
🐻 BEAR
At a P/E of 25.3 and EV/EBITDA of 14.9, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.